We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 15.875 | 15.50 | 16.25 | 15.875 | 15.875 | 15.88 | 165,889 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0125 | -12.70 | 35.89M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/10/2024 11:38 | SYME directors shud be stoned not fkn paid given their shareholders 99 pct losses great to watch though | thevladslayer | |
22/10/2024 11:36 | Come on, would you work for amount.? | sunshine today | |
22/10/2024 11:35 | 20's lol | thevladslayer | |
22/10/2024 11:26 | Pay him £40000 per year then to save the whining about tax. Do these guys want to contribute as little ro society as they do to PIs? | putinaire | |
21/10/2024 16:56 | DYOR Stuart J. Ashman (CEO) In post 5.5yrs. Remuneration £382,480 - £306,000 (2023, 20% reduction 2024). Total from appointment approx. £1,800,000+/-. Shares purchased: 125,000 (2020) paid £0.16 per share (total £20,000), 156,250 (2022) paid £0.16 per share (total £25,000). Number of shares held 276,804. Invested in company £45,000. % holding: 0.121%. Options held 5,189,444 at exercise price of £0.09 and £0.18. Manprit Randhawa (CFO) In post 2.3yrs. Remuneration £261,480 - £209,100 (2023, 20% reduction 2024). Total Remuneration from appointment approx. £500,000+/-. Shares purchased: 156,250 (2022) paid £0.16 per share (total £25,000). Number of shares held 153,165. % holding: 0.067%. Invested in company £25,000. Martin Hunt (Non-Executive Chairman) In post 8yrs. Remuneration/fees £68,670 (2023). Remuneration/fees from appointment £460,000+/-. Shares held 466,667 (2018): Buy 93,750 (2022) paid £0.16 per share (total £15,000). Number of shares held 560,417. Invested in company £15,000. % holding: 0.245%. Options held 3,892,082 at exercise price of £0.09. Cathy Prescott (Non-Executive Director) In post 7.6yrs. Remuneration/fees £41,011 (2023). Remuneration/fees from appointment £215,000+/-. Shares purchased: 56,112 (2019) paid £0.1782 (total £10,000): 62,500 (2020) paid £0.16 per share (total £10,000). 62,500 (2022) paid £0.16 per share (Total £10,000). Number of shares held 181,112. Invested in company £30,000. % holding: 0.079%. Danielle Bekker (Non-Executive Director) In post 2.5yrs. Remuneration/fees £25,000 (2023). Remuneration from appointment £56,250+/-. Shares purchased: 43,750 (2022) paid £0.16 per share (total £7,000). Invested in company £7,000. % holding: 0.019%. | theterrier | |
21/10/2024 15:52 | 20's soon fact | thevladslayer | |
21/10/2024 15:23 | I see nana is back from her friends funeral with her 3 pence worth of 15p buys again Looks like a few more million need dumping this week | putinaire | |
21/10/2024 09:08 | SBTX Ping loser | thevladslayer | |
21/10/2024 09:08 | SYME Pong loser | thevladslayer | |
21/10/2024 09:08 | RR Ping loser | thevladslayer | |
21/10/2024 09:07 | Min Ping loser | thevladslayer | |
21/10/2024 08:34 | Of course, with OPTI's request to PBX to create false market newsflows (re last rns), i suppose sbtx would be independent of all that scamming, what with opti not involved here at all lol | putinaire | |
20/10/2024 18:41 | Well they say what goes around comes around. But Opti and co, its stuff of dreams I reckon we will see pressure tactics kicking in from all over the world soon haha One eye | putinaire |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions